Development of a Robust Cytopathic Effect-Based High-Throughput Screening Assay To Identify Novel Inhibitors of Dengue Virus

We have developed a robust cytopathic effect-based high-throughput screening assay to identify inhibitors of dengue virus (DENY) infection. Screening of a small natural product library yielded 11 hits. Four of these were found to be potent inhibitors of DENY, although serotype differences were noted. Taken together, these data suggest that screening of larger and more complex molecule libraries may result in the identification of more potent and specific DENV inhibitors.